Author

Liang Cao

Institution: National Cancer Institute

Observed institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

OpenAlex ID: A5061216888

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

2023 · Aaron Scott Mansfield, Austin Goodrich, et al. · Journal of Clinical Oncology · 2

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

2022 · Aaron Scott Mansfield, Austin Goodrich, et al. · Journal of Clinical Oncology · 1

A phase 1/2 study of TRC105 in combination with sorafenib in hepatocellular carcinoma (HCC).

2015 · Austin G. Duffy, Chi Ma, et al. · Journal of Clinical Oncology

Works count: 3

Citation count: 3

H-index: 1

I10-index: